Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Kunz, Aline
219  Ergebnisse:
Personensuche X
?
1

AI-Derived Body Composition Parameters as Prognostic Factor..:

Müller, Lukas ; Mähringer-Kunz, Aline ; Auer, Timo Alexander...
JHEP Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

7-Dehydrocholesterol is an endogenous suppressor of ferropt..:

Freitas, Florencio Porto ; Alborzinia, Hamed ; dos Santos, Ancély Ferreira...
Nature.  626 (2024)  7998 - p. 401-410 , 2024
Link: https://doi.org/10.1038/..
 
?
3

A Novel Multi-Supplement Based on Guarana, Selenium, and L-..:

Moretto, Joana Grandó ; Vargas, Jose Eduardo ; da Silva, Julia Spanhol...
Revista Brasileira de Farmacognosia.  , 2024
Link: https://doi.org/10.1007/..
 
?
4

Ionic calcium variation in normal, acidic, alkaline and uns..:

da Luz Kunz, Shaeen Inaê ; do Nascimento, Aline Luiza ; da Silva, Cristina Bachmann...
International Journal of Dairy Technology.  , 2024
Link: https://doi.org/10.1111/..
 
?
5

A prospective cohort study of SARS-CoV-2 infection-induced ..:

Gehring, Stephan ; Kowalzik, Frank ; Okasha, Omar...
PLOS ONE.  19 (2024)  1 - p. e0294025 , 2024
Link: https://doi.org/10.1371/..
 
?
6

Comparison of SARS-CoV-2 incidence in this study and in the..:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.g002.  , 2024
Link: https://doi.org/10.1371/..
 
?
7

Duration of clinical symptoms of suspected COVID-19 cases:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.s006.  , 2024
Link: https://doi.org/10.1371/..
 
?
8

Incidence rates for symptomatic and severe COVID-19 disease..:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.t005.  , 2024
Link: https://doi.org/10.1371/..
 
?
9

Baseline characteristics, including demographics and COVID-..:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.s013.  , 2024
Link: https://doi.org/10.1371/..
 
?
10

Anti-SARS-CoV-2 anti-N IgG and anti-S seroprevalence at sch..:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.t003.  , 2024
Link: https://doi.org/10.1371/..
 
?
11

SARS-CoV-2 seroconversion rates at scheduled visits 2 to 6:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.t004.  , 2024
Link: https://doi.org/10.1371/..
 
?
12

Schedule of visits and number of subjects in each visit:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.s008.  , 2024
Link: https://doi.org/10.1371/..
 
?
13

Schedule of visits and number of subjects in each visit:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.s008.  , 2024
Link: https://doi.org/10.1371/..
 
?
14

Baseline characteristics, including demographics and COVID-..:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.t001.  , 2024
Link: https://doi.org/10.1371/..
 
?
15

SARS-CoV-2 RT-PCR testing algorithm:

Stephan Gehring ; Frank Kowalzik ; Omar Okasha...
doi:10.1371/journal.pone.0294025.s003.  , 2024
Link: https://doi.org/10.1371/..
 
1-15